Lactic Acidosis Induced by Metformin

[1]  H. D. Hoberman,et al.  Phenformin-associated Metabolic Acidosis , 1976, Diabetes.

[2]  X. Leverve,et al.  Mitochondrial metabolism and type-2 diabetes: a specific target of metformin. , 2003, Diabetes & metabolism.

[3]  L. Marroquin,et al.  Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. , 2008, Toxicology and applied pharmacology.

[4]  N. Wiernsperger.  What is This? Downloaded from , 2000 .

[5]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[6]  A. Maran,et al.  Protection by lactate of cerebral function during hypoglycaemia , 1994, The Lancet.

[7]  J. Lalau,et al.  Metformin and lactic acidosis in diabetic humans , 2000, Diabetes, obesity & metabolism.

[8]  H. Tildesley,et al.  Metformin's contraindications should be contraindicated , 2005, Canadian Medical Association Journal.

[9]  H. Krumholz,et al.  Thiazolidinediones, Metformin, and Outcomes in Older Patients With Diabetes and Heart Failure: An Observational Study , 2005, Circulation.

[10]  M. Stumvoll,et al.  Contraindications can damage your health—is metformin a case in point? , 2005, Diabetologia.

[11]  A. Fournier,et al.  Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. , 1989, International journal of clinical pharmacology, therapy, and toxicology.

[12]  P. Cryer,et al.  Effect of Hyperketonemia and Hyperlacticacidemia on Symptoms, Cognitive Dysfunction, and Counterregulatory Hormone Responses During Hypoglycemia in Normal Humans , 1994, Diabetes.

[13]  C. Bailey,et al.  Accumulation of metformin by tissues of the normal and diabetic mouse. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.

[14]  Xulei Tang,et al.  Metformin reverses the deleterious effects of high glucose on osteoblast function. , 2010, Journal of diabetes and its complications.

[15]  H. Howlett,et al.  Metformin therapy and clinical uses , 2008, Diabetes & vascular disease research.

[16]  S. Wild,et al.  Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[17]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[18]  E. Kilpatrick,et al.  Establishing pragmatic estimated GFR thresholds to guide metformin prescribing , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[19]  F. Andreelli,et al.  Metformin retention independent of renal failure in intestinal occlusion. , 2001, Diabetes & metabolism.

[20]  R. DeFronzo,et al.  Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. , 1996, The Journal of clinical endocrinology and metabolism.

[21]  R. D. Cohen.  Roles of the liver and kidney in acid-base regulation and its disorders. , 1991, British journal of anaesthesia.

[22]  R. Kreisberg,et al.  Lactate Turnover and Gluconeogenesis in Obesity: Effect of Phenformin , 1970, Diabetes.

[23]  O. Hamdy,et al.  Diabetes medications and body weight , 2009, Expert opinion on drug safety.

[24]  Leverve Xm.  Lactic acidosis. A new insight , 1999 .

[25]  C. Bailey,et al.  The Antihyperglycaemic Effect of Metformin , 2012, Drugs.

[26]  Yuichi Sugiyama,et al.  Involvement of Organic Cation Transporter 1 in Hepatic and Intestinal Distribution of Metformin , 2002, Journal of Pharmacology and Experimental Therapeutics.

[27]  B. Davis,et al.  Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention. , 2004, The American journal of cardiology.

[28]  J. Lalau,et al.  Lactic Acidosis in Metformin-Treated Patients , 1999 .

[29]  C. Bailey,et al.  Sites of metformin-stimulated glucose metabolism. , 1990, Biochemical pharmacology.

[30]  P. Montravers,et al.  Effect of metformin on survival rate in experimental sepsis. , 2006, Diabetes & metabolism.

[31]  J. Vincent,et al.  Lactate levels in critically ill patients , 1995, Acta anaesthesiologica Scandinavica. Supplementum.

[32]  J. Lalau,et al.  Unexpected recovery from prolonged hypoglycemic coma: a protective role of metformin? , 2005, Intensive Care Medicine.

[33]  M. Rigoulet,et al.  The ROS Production Induced by a Reverse-Electron Flux at Respiratory-Chain Complex 1 is Hampered by Metformin , 2006, Journal of bioenergetics and biomembranes.

[34]  C. Barber,et al.  The Effect of Intravenous Lactate on Cerebral Function During Hypoglycaemia , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[35]  Shuzhong Zhang,et al.  Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. , 2007, The Journal of clinical investigation.

[36]  A. Scheen.  Clinical Pharmacokinetics of Metformin , 1996, Clinical pharmacokinetics.

[37]  S. Nseir,et al.  Metformin-associated lactic acidosis : A prognostic and therapeutic study * , 2009 .

[38]  C. Day,et al.  Effect of metformin on glucose metabolism in the splanchnic bed , 1992, British journal of pharmacology.

[39]  C. Bailey,et al.  Subcellular distribution of metformin in rat liver , 1991, The Journal of pharmacy and pharmacology.

[40]  K. Alberti,et al.  Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics , 1977, Diabetologia.

[41]  M. Prikis,et al.  When a friend can become an enemy! Recognition and management of metformin-associated lactic acidosis. , 2007, Kidney international.

[42]  A. Bergeret,et al.  Consequences of metformin intoxication. , 1998, Diabetes care.

[43]  J. Girard,et al.  Metformin-induced lactic acidosis in the presence of acute renal failure , 1977, Diabetologia.

[44]  J. Lalau,et al.  Lactic Acidosis in Metformin Therapy: Relationship between plasma metformin concentration and renal function , 1998, Diabetes Care.

[45]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[46]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[47]  B. Draznin,et al.  Mitogenic action of insulin: friend, foe or ‘frenemy’? , 2010, Diabetologia.

[48]  D. Cryer,et al.  Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study. , 2005, Diabetes care.

[49]  J. Lalau,et al.  Lactic acidosis in metformin therapy: searching for a link with metformin in reports of ‘metformin‐associated lactic acidosis’ , 2001, Diabetes, obesity & metabolism.

[50]  E. Bosisio,et al.  Metformin Improves Peripheral Vascular Flow in Nonhyperlipidemic Patients with Arterial Disease , 1984, Journal of cardiovascular pharmacology.

[51]  S. Amiel,et al.  Hypoglycaemia in Type 2 diabetes , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[52]  S. Majumdar,et al.  Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. , 2002, Diabetes care.

[53]  X. Leverve,et al.  Neuroprotective Role of Antidiabetic Drug Metformin Against Apoptotic Cell Death in Primary Cortical Neurons , 2007, Journal of Molecular Neuroscience.

[54]  M. Feher,et al.  Metformin‐associated lactic acidosis: a rare or very rare clinical entity? , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[55]  F. Holleman,et al.  Metformin and lactic acidosis: cause or coincidence? A review of case reports , 2004, Journal of internal medicine.

[56]  L. Fontana,et al.  Modulating human aging and age-associated diseases. , 2009, Biochimica et biophysica acta.

[57]  M. Owen,et al.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.

[58]  M. Nyirenda,et al.  Severe acidosis in patients taking metformin—rapid reversal and survival despite high APACHE score , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[59]  E. Salpeter,et al.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. , 2010, The Cochrane database of systematic reviews.

[60]  G. Divine,et al.  Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus. , 2010, The Journal of clinical endocrinology and metabolism.

[61]  Jonathan B. Brown,et al.  Lactic Acidosis Rates in Type 2 Diabetes , 1998, Diabetes Care.

[62]  J. Idle,et al.  Genetic polymorphism of phenformin 4‐hydroxylation , 1982, Clinical pharmacology and therapeutics.

[63]  S. Krähenbühl,et al.  Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia , 2008, Diabetes Care.

[64]  G. Searle,et al.  Lactic Acidosis Associated with Phenformin Therapy: Evidence that Inhibited Lactate Oxidation is the Causative Factor , 1975, Diabetes.

[65]  A. Morris,et al.  Contraindications to metformin therapy in patients with Type 2 diabetes—a population‐based study of adherence to prescribing guidelines , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[66]  C. Sirtori,et al.  Treatment with low dose metformin in patients with peripheral vascular disease. , 1992, Pharmacological research.

[67]  J. Fraser,et al.  Uncommon cause of cardiac arrest in the emergency department , 2007, Emergency medicine Australasia : EMA.

[68]  H. Kusuhara,et al.  Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. , 2003, Molecular pharmacology.

[69]  J. Lalau,et al.  Measurement of metformin concentration in erythrocytes:clinical implications , 2003, Diabetes, obesity & metabolism.

[70]  D. Lefer,et al.  1116-1 Preconditioning of the diabetic myocardium with acute metformin treatment , 2004 .

[71]  A. Morris,et al.  Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin , 2006, Diabetologia.

[72]  A. Tahrani,et al.  Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? , 2007, BMJ : British Medical Journal.

[73]  S. Ahmad,et al.  Recovery from ph 6.38: lactic acidosis complicated by hypothermia , 2002, Emergency medicine journal : EMJ.

[74]  X. Leverve,et al.  Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. , 2005, Diabetes.

[75]  C. Barber,et al.  Intravenous lactate prevents cerebral dysfunction during hypoglycaemia in insulin-dependent diabetes mellitus. , 1998, Clinical science.

[76]  A. Arieff.  Pathogenesis of lactic acidosis. , 1989, Diabetes/metabolism reviews.

[77]  M. Ravid,et al.  Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications. , 2002, European journal of internal medicine.

[78]  A. Golay.  Metformin and body weight , 2008, International Journal of Obesity.

[79]  A. Holstein,et al.  Contra‐indications to metformin therapy are largely disregarded , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[80]  J. Tayek.  Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936 , 2006, Diabetologia.

[81]  D. Balzi,et al.  Are sulphonylureas all the same? A cohort study on cardiovascular and cancer‐related mortality , 2007, Diabetes/metabolism research and reviews.

[82]  C. Lacroix,et al.  [Microassay of plasma and erythrocyte metformin by high performance liquid chromatography]. , 1991, Annales de biologie clinique.

[83]  H. F. Woods,et al.  Clinical and biochemical aspects of lactic acidosis , 1976 .

[84]  F. Isnard,et al.  Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly). , 1990, International journal of clinical pharmacology, therapy, and toxicology.

[85]  W. Alexander,et al.  Contraindications to the use of metformin , 2003, BMJ : British Medical Journal.

[86]  M. Andréjak,et al.  Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects. , 2003, Diabetes & metabolism.

[87]  R. Misbin.  The phantom of lactic acidosis due to metformin in patients with diabetes. , 2004, Diabetes care.

[88]  R. H. Williams,et al.  Farewell to phenformin for treating diabetes mellitus. , 1975, Annals of internal medicine.

[89]  P. Loirat,et al.  Role of Metformin Accumulation in Metformin-Associated Lactic Acidosis , 1995, Diabetes Care.

[90]  J. Radziuk,et al.  Effects of Metformin on Lactate Uptake and Gluconeogenesis in the Perfused Rat Liver , 1997, Diabetes.

[91]  J. Rungby,et al.  Survival following a metformin overdose of 63 g: a case report. , 2003, Pharmacology & toxicology.

[92]  A. Arieff,et al.  Lactic acidosis and the cardiovascular system in the dog. , 1983, Clinical science.

[93]  P. Donnan,et al.  New Users of Metformin Are at Low Risk of Incident Cancer , 2009, Diabetes Care.

[94]  B. Morgan,et al.  Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature. , 2009, Annals of emergency medicine.

[95]  Ross T Tsuyuki,et al.  Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. , 2005, Diabetes care.

[96]  A. Marble,et al.  Oral Hypoglycaemic Agents , 1984, Drugs.

[97]  L. Cady,et al.  Quantization of severity of critical illness with special reference to blood lactate , 1973, Critical care medicine.

[98]  W. Knaus,et al.  The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. , 1991, Chest.

[99]  Shari Bolen,et al.  Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus , 2007, Annals of Internal Medicine.

[100]  M. Eggstein,et al.  Definition of clinically relevant lactic acidosis in patients with internal diseases. , 1983, American journal of clinical pathology.

[101]  R.R. Patel.  Thiazolidinediones and Congestive Heart Failure: A Judicious Balance of Risks and Benefits , 2009, Cardiology in review.

[102]  M H Weil,et al.  Experimental and Clinical Studies on Lactate and Pyruvate as Indicators of the Severity of Acute Circulatory Failure (Shock) , 1970, Circulation.

[103]  P. Tesauro,et al.  [The use of metformin in ischemic cardiopathy]. , 1980, La Clinica terapeutica.